Skip to Content

N 894 150 (Nizatidine 150 mg)

Pill with imprint N 894 150 is Brown & White, Capsule-shape and has been identified as Nizatidine 150 mg. It is supplied by Teva Pharmaceuticals USA.

Nizatidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; indigestion (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 894 150

Nizatidine 150 mg N 894 150

Nizatidine

Imprint:
N 894 150
Strength:
150 mg
Color:
Brown & White
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide